The evaluation of the expression profile of PGRN in various brain tumour cell lines, including glioma (H4), GBM (U87, GBM8904, S1R1, PT3) and neuroblastoma (Daoy), was performed in a comprehensive study conducted by Bandey et al. [103]. Here, GRN is linked to central nervous system cancer.